Department of Internal Medicine, San Matteo Hospital Foundation, Pavia, Italy.
Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico and Università degli Studi di Milano, Milan, Italy.
Expert Rev Gastroenterol Hepatol. 2022 Jul;16(7):625-637. doi: 10.1080/17474124.2022.2089114. Epub 2022 Jun 20.
Anemia is a common complication of gastrointestinal (GI) disorders, with a prevalence up to 60% in celiac disease (CeD) and inflammatory bowel disease (IBD). Iron deficiency anemia (IDA) is the most prevalent form of anemia in these conditions, but chronic inflammation and vitamin B12 deficiency represent other common contributing mechanisms, especially in IBD.
We discuss the pathogenesis of anemia in various medical GI disorders, the sometime problematic distinction between IDA, anemia of inflammation (AI) and the association of the two, and therapeutic and preventive measures that can be useful for the management of anemia in GI disorders. Unfortunately, with the exception of IDA and AI in IBD, large RCT concerning the treatment of anemia in GI disorders are lacking.
Anemia management strategies in GI disorders are outlined, with a focus on the main prevention, diagnostic, and therapeutic measures. Specific problems and situations such as the role of gluten-free diet for IDA treatment in CeD, the choice between oral and parenteral supplementation of iron or vitamin B12 in carential anemias, the use of endoscopic procedures to stop bleeding in intestinal angiodysplasia and preventive/treatment strategies for NSAID-associated GI bleeding are discussed.
贫血是胃肠道(GI)疾病的常见并发症,在乳糜泻(CeD)和炎症性肠病(IBD)中患病率高达 60%。缺铁性贫血(IDA)是这些疾病中最常见的贫血形式,但慢性炎症和维生素 B12 缺乏是其他常见的致病机制,尤其是在 IBD 中。
我们讨论了各种医学 GI 疾病中贫血的发病机制,有时在 IDA、炎症性贫血(AI)和两者的关联之间存在问题,以及可用于治疗 GI 疾病中贫血的治疗和预防措施。不幸的是,除了 IBD 中的 IDA 和 AI 之外,缺乏关于 GI 疾病中贫血治疗的大型 RCT。
概述了 GI 疾病中贫血的管理策略,重点关注主要的预防、诊断和治疗措施。讨论了特定的问题和情况,例如无麸质饮食在 CeD 中治疗 IDA 的作用、口服和肠外补充铁或维生素 B12 在缺铁性贫血中的选择、内镜程序在治疗肠道血管发育不良出血中的作用以及 NSAID 相关 GI 出血的预防/治疗策略。